Virus phenotype switching and disease progression in HIV-1 infection

Proceedings of the Royal Society B: Biological Sciences

Volumn 266, Issue 1437, 1999, Pages 2523-2530

  Callaway, Duncan S ^a,c   Ribeiro, Ruy M ^a   Nowak, Martin A ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSTITUTE FOR ADVANCED STUDY   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

HIV 1; Mathematical model; Non syncitium inducing; Phenotype switch; Syncytium inducing

Indexed keywords

ARTICLE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; MATHEMATICAL MODEL; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL;

EID: 0033596278     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.1999.0955     Document Type: Article

References (61)

1. Anderson, R. A. & May, R. M. 1993 Infectious diseases of humans, 3rd edn. London: Oxford University Press.
2. Anzahl, O. A., Nagelkerke, N. J., Bwayo, J. J., Holton, D., Moses, S., Ngugi, E. N., Ndinya-Achola, J. O. & Plummer, F. A. 1995 Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J. Infect. Dis. 171, 686 689.
3. Baur, A., Scwarz, N., Ellinger, S., Korn, K., Harrer, T., Mang, K. & Jahn, G. 1989 Continuous clearance of HIV in a vertically infected child. Lancet ii, 1045.
4. Berger, E. A. 1997 HIV entry and tropism: the chemokine receptor connection. AIDS 11, S3 S16.
5. Bonhoeffer, S., Holmes, E. C. & Nowak, M. A. 1995 Causes of HIV diversity. Mature 376, 125.
6. Bonhoeffer, S., Coffin, J. M. & Xovvak, M. A. 1997 Human immunodeficiency virus drug therapy and virus load. J. Viral. 71, 3275 3278.
7. Boucher, C. A. B. & Reedjik, M. 1995 Viral resistance: a major challenge in managing HIV disease. J. Biol. Regul. Homeo. Agents 9, 91 94.
8. Bouhabib, D. C., Roderiquez, G., Oravecz, T., Berman, P. W., Lusso, P. & Norcross, M. A. 1994 Cryptic nature of envelope V3 region epitopes protects primary monocylotropic human-immunodeficiency-virus type-1 from antibody neutralization. J. Virol. 68, 6006 6013.
9. Bukrinsky, M. I., Stanwick, T. L., Dempsey, M. P. & Stevenson, M. 1991 Quiescent lymphocytes-Tas an inducible virus reservoir in HIV-1 infection. Science 254, 423-427.
10. Coffin, J. M. 1995 HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483 489.
11. Connor, R. I., Mohri, H., Cao, Y. & Ho, D. D. 1993 Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type-1 infected individuals. J. Virol. 67, 1772 1777.
12. Cornelissen, M. (and 10 others) 1995 Syncylium inducing (SI; phenotype suppression at scroconversion after intramuscular inoculation of a non-syncytium inducing/SI phenotypically mixed human immunodeficiency population. J. Virol. 69, 1810 1818.
13. De Jong, J. J., De Ronde, A., Keulen, W., Tersmette, M. & Goudsmit, J. 1992 Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncitium-inducing phenotype: analysis by single amino acid substitution. J. Viral. 66, 6777 6780.
14. Fauci, A. S. 1996 Host factors and the pathogenesis of HIV-induced disease. Nature 384, 529 534.
15. Fouchier, R. A. M., Groenink, M., Kootstra, N. A., Tersmette, M., Huisman, H. G., Miedema, F. & Schuitemaker, H. 1992 Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type1 gpl20 molecule. J. Virol. 66, 3183-3187.
16. Fouchier, R. A. M., Meyaard, L., Brouwer, M., Hovenkamp, K. & Schuitemaker, H. 1996 Broader tropism and higher cytopathicity for CD4+ T-cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolates a mechanism for accelerated CD4+ T cell decline in vivo. Virology 219, 87 95.
17. Gartner, S., Markovits, P., Markovits, D. M., Kaplan, M. H., Gallo, R. C. & Popovic, M. 1986 The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233, 215-219.
18. Goulder, P. J. R. (and 11 others) 1997 Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS, .Nature Med. 3, 212-217.
19. Grivel, J.-C. & Margolis, L, B. 1999 CCR5-and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. ,Nature Med. 5, 344 346.
20. Groenink, K. M., Fouchier, R. A. M., De Goede, R. R. V, De Wolf, K, Gruters, R. A., Cuypers, T. M., Huisman, H. G. & Tersmette, M. 1991 Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type-1 clones derived from a single individual. J. Virol. 65, 1968-1975.
21. Haas, G. fand 12 others; 1996 Dynamics of viral variants in HIV-1 nef and specific cytotoxic T lymphocytes in vivo. J. Immunol. 157, 4212-4221.
22. Haynes, B. F., Pantaleo, G. & Fauci, A. S. 1996 Toward an understanding of the correlates of protective immunity to HIV infection. Science 271, 324-328.
23. Herhein, G., Mahlknecht, U, Batliwalla, F., Gregersen, P., Pappas, T., Butler, J., O'Brien, W A. & Verdin, E. 1998 Apoptosis of CD8+ T cells is mediated by macrophages through interaction with HIV gpl20 with chemokine receptor CXCR4. Nature 395, 189 194.
24. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. 1995 Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123 126.
25. Kalams, S. A. & Walker, B. D. 1998 The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188, 2199-2204.
26. Koenig, S., Gendelman, H. E., Orenstein, J. M., Dal Canto, M. C., Pezeshpour, G. H., Yungbluth, M., Janotta, F., Aksamit, A., Martin, M. A. & Fauci, A. S. 1986 Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233, 1089 1093.
27. Koot, M., van't Wout, A. B., Kootstra, N. A., De Goede, R. E., Tersmette, M. & Schuitemaker, H. 1996 Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J. Inject. Dis. 173, 349 354.
28. Root, M., Van Leeuwen, R., De Goede, R. E., Keet, I. P., Danner, S., Eeftinck Schattenkerk, J. K., Reiss, P., Tersmette, M., Lange, J. M. & Schuitemaker, H. 1999 Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis. J. Infect. Dis. 179, 254-258.
29. Knup, R. A., Safrit, J. T., Cao, Y. Z., Andrews, C. A., McLeod, G., Borkowsky, W, Farthing, C. & Ho, D. D. 1994 Temporal association of cellular immune-responses with the initial control of viremia in primary human-immunodeficiency-virus type-1 syndrome. J. Viral. 68, 4650 4655.
30. Loveday, C., Kay, S., Tenant-Flowers, M., Semple, M., Ayliffe, U., Weller, I.V. D. & Tedder, R. S. 1995 HIV-1 RXA serum-load and resistant viral genotypes during early zidovudine therapy. Lancet 345, 820 824.
31. Mackewicz, C. E., Ortega, H. W. & Levy, J. A. 1991 CD8+ cell anti-HIV activity correlates with the clinical state of the infected individuals. J. Clin. Invest. 87, 1462 1466.
32. McLean, A. R. & Kirkwood, T. B. L. 1990 A model of human immunodeficiency virus infection in T helper cell clones. J. Theor. Biol. 147, 177 203.
33. McLean, A. R. & Nowak, M. A. 1992 Models of interaction between HIV and other pathogens. J. Theor. Biol. 155, 69 86.
34. Mi-Michael, A. J. & O'Callaghan, C. A. 1998 A new look at T cells. J. Exp. Med. 187, 1367-1371.
35. Mellors, J.W., Rinaldo Jr. C. R., Gupta, P., White, R. M.,Todd, J. A. & Kingsley, L. A. 1996 Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167 1170.
36. Miedema, F. (and 10 others) 199-1-Changing virus-host inter-actions in the course of HIV-1 infection. Immunol. Rev. 140, 35-72.
37. Nagelkerke, N. J., Plummer, F. A., Holton, D., Anzala, A. O., Manji, F., Ngugi, K. N. & Moses, S. 1990 Transition dynamics of HIV disease in a cohort of African prostitutes: a Markov model approach. AIDS 4, 743 747.
38. Nowak, M. A. & May, R. M. 1991 Mathematical biology of HIV infections - antigenic variation and diversity thresholds. Math. Biosci. 106, 1 21.
39. Nowak, M. A., Anderson, R. M., McLean, A. R., Wolfs, T. F. W., Goudsmit, J. & May, R. M. 1991 Antigenic diversity thresholds and the development of AIDS. Science 254, 963 969.
40. Ogg, G. S. (and 14 others) 1998 Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103 2106.
41. Osirowski, M. A., Krakauer, D. C., Li, Y., Justement, S. J., Learn, G., Ehler L. A., Stanley, S. K., Nowak, M. A. & Fauci, A. S. 1998 Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasi-species. J. Virol. 72, 7772-7784.
42. Pantaleo, G. & Fauci, A. S. 1996 Immunopathogenesis of HIV infection. A. Rer. Micrombiol. 50, 825 -854.
43. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. 1996 HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, viral generation time. Science 271, 1582-1586.
44. Phair, J. P. 1994 Keynote address: variations in the natural history of HIV infection. AIDS Res. Hum. Retroviruses. 10, 883-885.
45. Pratt, R. D., Shapiro, J. F., McKinney, N., Kwok, S. & Speetor, S. A. I995 Virologic characterization of primary human immunodeficiency virus type 1 infection in a health care worker following needlestick injury. J. Inject. Dis. 172, 851-854.
46. Price, D. A., Goulder, P. J. R., Klenerman, P., Sewell, A. K., Easterbrook, P. J., Troop, M., Bangham, C. R. M. & Phillips, R. L. 1997 Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl Acad. Sci. USA 94, 1890 1895.
47. Quinn, T. C., Piot, P., McCormick, J. R., Feinsod, F. M., Tuelman, H., Kapita, B., Stevens, W. & Fauci, A. S. 1987 Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. J. Am. Med. Assoc. 257, 2617 2621.
48. Ribeiro, R. M., Bonhoeffer, S. & Nowak, M. A. 1998 The frequency of resistant mutant virus before antiviral therapy. AIDS 12, 461-465.
49. Richman, D. D. 1996 HIV drug resistance - an overview. AIDS 10, S121.
50. Roos, M. T. L., Lange, J. M. A., De Goede, R. L. Y, Coutinho, R. A., Schellekens, P. T. A., Miedema, F. & Tersmette, M. 1992 Yiral phenotype and immune response in primary human immunodeficiency virus type-1 infection. J. Infect. Dis. 165, 427-432.
51. Rosenberg, F. S. & Walker, B. 13. 1998 HIV type 1-specific helper T-cells: a critical host defense. AIDS Res. Hum. Retroviruses 14, S143-S147.
52. Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A. & Walker, B. D. 1997 Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447-1450.
53. Safrit, J. T. & Koup, R. A. 1995 The immunology of primary HIV infection - which immune responses control HIV replication, Curr. Opin. Immunol. 7, 456 461.
54. Schuitemaker, H., Koot, M., Kootstra, N. A., Dereksen, M. W., de Goede, R. E., van Steenwijk, R. P., Lange, J. M., Schattenkerk, J. K., Miedema, F. & Tersmette, M. 1992 Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66, 1354 1360.
55. Stevenson, M. 1996 Portals of entry - uncovering HIV nuclear transport pathways. Trends Cell Biol. 6, 9 15.
56. Tersmette, M., Gruters, R. A., De Wolf, F., Dde Goede, R. E. Y, Lange, J. M. A., Sehellekens, P. T. A., Goudsmit, J., Huisman, H. G. & Miedema, F. 1989 Evidence for a role of virulent human immunodeficiency virus (HIV) variants in pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63, 2118 2125.
57. Van't Wout, A. B., Kootstra, N. A., Mulder-Kampinga, G. A., Albrecht-van Lent, N., Scherpbier, H. J., Venstra, J., Boer, K., Coutinho, R. A., Miedema, F. & Schuitemaker, H. 1994 Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral and vertical transmission. J. Clin. Invest 94, 2060 2067.
58. Wei, X. (and 11 others) 1995 Viral dynamics in human immunodeficiency type-1 infection. Nature 373, 117-122.
59. Wodarz, D. & Novvak, M. A. 1998 The effect of different immune responses on the evolution of virulent CXCR4-tropic HIV Proc. R. Sac. Lond. B 265, 2149 2158.
60. Wodarz, D., Lloyd, A. L., Jansen, V. A. A. & Nowak, M. A. 1999 Dynamics of macrophage and T cell infection by HIV. J. Theor. Rial. 196, 101 113.
61. Zhu, T., Mo, H., Wang, N., Nam, D., Cao, Y, Koup, R. & Ho, D. D. 1993 Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261, 1179-1181.